Young Stephanie Ming, Kim Yoon-Duck, Woo Kyung In
Eagle Eye Centre, Singapore.
Department of Ophthalmology, Nune Eye Hospital, Seoul, Korea.
Taiwan J Ophthalmol. 2023 May 23;14(4):548-553. doi: 10.4103/tjo.TJO-D-23-00043. eCollection 2024 Oct-Dec.
Upper eyelid retraction (UER) is the most common sign of thyroid eye disease (TED) and may result in lagophthalmos and exposure keratopathy. Measures to address UER are varied and include conservative treatment, surgical intervention, and injections of botulinum toxin, hyaluronic acid (HA) filler, and triamcinolone acetonide (TA). Our article will discuss the various nonsurgical aspects of managing TED-related UER, focusing on the injections of botulinum toxin, HA filler, and TA to the upper eyelid, which have all been reported to be effective in improving UER in both active and inactive states of TED. Individual response may vary, and repeated injections may be necessary.
上睑退缩（UER）是甲状腺眼病（TED）最常见的体征，可能导致兔眼和暴露性角膜病变。解决上睑退缩的措施多种多样，包括保守治疗、手术干预以及注射肉毒杆菌毒素、透明质酸（HA）填充剂和曲安奈德（TA）。我们的文章将讨论甲状腺眼病相关上睑退缩管理的各种非手术方面，重点关注向上眼睑注射肉毒杆菌毒素、HA填充剂和TA，据报道这些方法在甲状腺眼病的活动期和非活动期均能有效改善上睑退缩。个体反应可能有所不同，可能需要重复注射。
